BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6798427)

  • 1. Effects of sodium valproate on the serum protein binding of phenytoin, and on liver enzyme activity.
    Richens A; Makki K; Monks A; Oxley J; Laidlaw J
    Monogr Neural Sci; 1980; 5():221-8. PubMed ID: 6798427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of hepatic enzyme inducing effect of sodium valproate.
    Oxley J; Hedges A; Makki KA; Monks A; Richens A
    Br J Clin Pharmacol; 1979 Aug; 8(2):189-90. PubMed ID: 385027
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between phenytoin and valproate.
    Sansom LN; Beran RC; Schapel GJ
    Med J Aust; 1980 Aug; 2(4):212. PubMed ID: 6776391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.
    Perucca E; Hedges A; Makki KA; Ruprah M; Wilson JF; Richens A
    Br J Clin Pharmacol; 1984 Sep; 18(3):401-10. PubMed ID: 6435654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of valproate on free plasma phenytoin concentrations.
    Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients.
    Monks A; Richens A
    Clin Pharmacol Ther; 1980 Jan; 27(1):89-95. PubMed ID: 6985856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects.
    Perucca E; Hebdige S; Frigo GM; Gatti G; Lecchini S; Crema A
    Clin Pharmacol Ther; 1980 Dec; 28(6):779-89. PubMed ID: 6777108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma protein binding of phenytoin in patients on valproic acid.
    Dahlqvist R; Borgå O; Rane A; Walsh Z; Sjöqvist F
    Br J Clin Pharmacol; 1979 Dec; 8(6):547-52. PubMed ID: 391256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we routinely measure free plasma phenytoin concentration?
    Rimmer EM; Buss DC; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jan; 17(1):99-102. PubMed ID: 6419764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid in epilepsy: clinical and pharmacological effects.
    Mattson RH; Cramer JA; Williamson PD; Novelly RA
    Ann Neurol; 1978 Jan; 3(1):20-5. PubMed ID: 350128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of valproic acid on liver function.
    de Wolff FA; Peters AC; van Kempen GM
    Arch Toxicol Suppl; 1983; 6():369-73. PubMed ID: 6138013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of phenytoin clearance by valproic acid in normal subjects.
    Frigo GM; Lecchini S; Gatti G; Perucca E; Crema A
    Br J Clin Pharmacol; 1979 Dec; 8(6):553-6. PubMed ID: 391257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate.
    de Wolff FA; Peters AC; van Kempen GM
    Neuropediatrics; 1982 Feb; 13(1):10-3. PubMed ID: 6123089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
    O'Leary TD; Sansom LN
    J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism.
    Wietholtz H; Zysset T; Kreiten K; Kohl D; Büchsel R; Matern S
    Eur J Clin Pharmacol; 1989; 36(4):401-6. PubMed ID: 2500346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium valproate on plasma protein binding of diphenylhydantoin.
    Patsalos PN; Lascelles PT
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):570-4. PubMed ID: 20483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate.
    Kober A; Olsson Y; Sjöholm I
    Mol Pharmacol; 1980 Sep; 18(2):237-42. PubMed ID: 6775182
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous valproate: effects on plasma and saliva phenytoin levels.
    Pisani FD; Di Perri RG
    Neurology; 1981 Apr; 31(4):467-70. PubMed ID: 6783979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of valproic acid with phenytoin.
    Bruni J; Gallo JM; Lee CS; Perchalski RJ; Wilder BJ
    Neurology; 1980 Nov; 30(11):1233-6. PubMed ID: 6775245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.